Literature DB >> 51647

Analysis of inhibition of lymphocyte cytotoxicity in human colon carcinoma.

A P Nind, N Matthews, E A Pihl, J M Rolland, R C Nairn.   

Abstract

Serum inhibition of autochthonous lymphocyte cytotoxicity for tumour cells has been studied in 112 cases of colonic carcinoma. Addition of patient's serum to the lymphocyte tumour cell reaction mixture resulted in decreased cytotoxic reactivity of lymphocytes from 8 of 39 cytotoxic positive cases. It was also shown that sera could inhibit if separately preincubated with the lymphocytes (4 cases) or the target cells (2 cases). A tumour antigen preparation inhibited only when incubated with the lymphocytes. Inhibition by serum or antigen appeared to be specific for colon carcinoma. Four cases were specially studied to determine the mode of lymphocyte killing of tumour cells: in 3 it was mediated largely if not entirely by T lymphocytes, and in the fourth by both T and non-T cells. The findings support the view that T lymphocytes lose their anti-tumour reactivity in vivo in the presence of circulating antigen or antigen-antibody complexes such as would occur with progressive tumour growth.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 51647      PMCID: PMC2009473          DOI: 10.1038/bjc.1975.108

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  12 in total

1.  Cytotoxicity of human rosette-forming blood lymphocytes on cultivated human tumor cells.

Authors:  J Wybran; I Hellström; K E Hellström; H H Fudenberg
Journal:  Int J Cancer       Date:  1974-04-15       Impact factor: 7.396

2.  Electron microscope observations of the in vitro interaction between human leucocytes and cancer cells.

Authors:  E Pihl; A P Nind; R C Nairn
Journal:  Aust J Exp Biol Med Sci       Date:  1974-10

3.  Sequential studies on cell-mediated tumor immunity and blocking serum activity in ten patients with malignant melanoma.

Authors:  I Hellström; G A Warner; K E Hellström; H O Sjögren
Journal:  Int J Cancer       Date:  1973-03-15       Impact factor: 7.396

4.  Inhibition of lymphocyte cytotoxicity for human colon carcinoma by treatment with solubilized tumour membrane fractions.

Authors:  R W Baldwin; M J Embleton; M R Price
Journal:  Int J Cancer       Date:  1973-07-15       Impact factor: 7.396

5.  Rosette-formation between human lymphocytes and sheep red cells not involving immunoglobulin receptors.

Authors:  R R Coombs; B W Gurner; A B Wilson; G Holm; B Lindgren
Journal:  Int Arch Allergy Appl Immunol       Date:  1970

6.  Immunological reactivity in patients with carcinoma of colon.

Authors:  R C Nairn; A P Nind; E P Guli; D J Davies; J M Rolland; A R McGiven; E S Hughes
Journal:  Br Med J       Date:  1971-12-18

7.  Lymphoid cells mediating tumor-specific cytotoxicity to carcinoma of the urinary bladder. Separation of the effector population using a surface marker.

Authors:  C O'Toole; V Stejskal; P Perlmann; M Karlsson
Journal:  J Exp Med       Date:  1974-03-01       Impact factor: 14.307

8.  Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells.

Authors:  M Jondal; G Holm; H Wigzell
Journal:  J Exp Med       Date:  1972-08-01       Impact factor: 14.307

9.  A common tumour specific antigen. I. Restriction in vivo to malignant neoplastic tissue.

Authors:  J P Dickinson; E A Caspary; E J Field
Journal:  Br J Cancer       Date:  1973-02       Impact factor: 7.640

10.  Lymphocyte anergy in patients with carcinoma.

Authors:  A P Nind; R C Nairn; J M Rolland; E P Guli; E S Hughes
Journal:  Br J Cancer       Date:  1973-08       Impact factor: 7.640

View more
  5 in total

1.  An approach to the routine estimation of circulating carcinoembryonic antigen immune complexes in patients with carcinomata of the gastrointestinal tract.

Authors:  K Kapsopoulou-Dominos; F A Anderer
Journal:  Clin Exp Immunol       Date:  1979-07       Impact factor: 4.330

2.  Colonic carcinoma: clinicopathological correlation with immunoreactivity.

Authors:  E Pihl; E S Hughes; A P Nind; R C Nairn
Journal:  Br Med J       Date:  1975-09-27

3.  [Relapse prognosis for patients with adenocarcinoma of the gastrointestinal tract on the basis of carcinoembryonic antigen (CEA) and its circulating immune complexes (author's transl)].

Authors:  H J Staab; F A Anderer; E Stumpf; R Fischer
Journal:  Klin Wochenschr       Date:  1980-02-01

4.  Characterization of cytotoxic spleen cells and effects of serum factors in a syngeneic rat tumour system.

Authors:  N Matthews; P J Chalmers; G R Flannery; R C Nairn
Journal:  Br J Cancer       Date:  1976-03       Impact factor: 7.640

5.  Immunoreactivity by intrinsic lymphoid cells in colorectal carcinoma.

Authors:  J A Werkmeister; E Pihl; A P Nind; G R Flannery; R C Nairn
Journal:  Br J Cancer       Date:  1979-12       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.